AXL and renal cell carcinoma: Together, results from Fig. 4a–f suggest that TR4 could modulate the lncTASR expression via transcriptional regulation, which might then alter the AXL protein expression via enhancing the stability of AXL mRNA to increase the RCC sunitinib resistance.